 Pancytopenia secondary short-term high-dose intravenous infusion amrinone incidence amrinone-induced thrombocytopenia percent patients intravenous therapy date reports patients reports hematologic abnormalities administration case report patient hematologic values days amrinone therapy nadir day Values days treatment report first evidence amrinone pancytopenia patients short courses high-dose continuous-infusion amrinone